PTK2 and head and neck squamous cell carcinoma: Furthermore, this nano-co-delivery system exhibited RNA therapy through targeting and inhibiting the expression of oncogene FAK. FAK participates in the cell-extracellular matrix interactions and demonstrates upregulation in HNSCC and laryngeal epithelial precursor lesions [32].